113 related articles for article (PubMed ID: 2993497)
21. Biologic significance of the detection of HBsAg and HBcAg in liver and tumor from 204 HBsAg-positive patients with primary hepatocellular carcinoma.
Hsu HC; Wu TT; Sheu JC; Wu CY; Chiou TJ; Lee CS; Chen DS
Hepatology; 1989 May; 9(5):747-50. PubMed ID: 2540083
[TBL] [Abstract][Full Text] [Related]
22. Effect of Oenanthe javanica flavone on human and duck hepatitis B virus infection.
Wang WN; Yang XB; Liu HZ; Huang ZM; Wu GX
Acta Pharmacol Sin; 2005 May; 26(5):587-92. PubMed ID: 15842778
[TBL] [Abstract][Full Text] [Related]
23. Effect of interferon on the production of HBsAg and induction of an antiviral state in human hepatoma cell line PLC/PRF/5.
Nakajima Y; Kuwata T; Tomita Y; Okuda K
Microbiol Immunol; 1982; 26(8):705-12. PubMed ID: 6294485
[TBL] [Abstract][Full Text] [Related]
24. Purification of HBsAg produced by the human hepatoma cell line PLC/PRE/5 by affinity chromatography using monoclonal antibodies and application for ELISA diagnostic.
Merten OW; Reiter S; Scheirer W; Katinger H
Dev Biol Stand; 1983; 55():121-7. PubMed ID: 6329855
[TBL] [Abstract][Full Text] [Related]
25. Relationship between depression of HBsAg production and DNA synthesis by interferons in human hepatoma cell line.
Hajnická V; Stancek D; Fuchsberger N; Kubes M
Acta Virol; 1990 Feb; 34(1):44-8. PubMed ID: 1975724
[TBL] [Abstract][Full Text] [Related]
26. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences.
Mabit H; Dubanchet S; Capel F; Dauguet C; Petit MA
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2681-9. PubMed ID: 7931154
[TBL] [Abstract][Full Text] [Related]
27. Recombinant hepatitis B virus surface antigen formulated with B-type CpG oligodeoxynucleotide induces therapeutic immunity against hepatitis B virus surface antigen-expressing liver cancer cells in mice.
Zhou X; Wei H; Sun P; Wu X; Wan M; Zhang P; Guo S; Zhao T; Yu Y; Wang L
Cancer Biother Radiopharm; 2012 May; 27(4):234-42. PubMed ID: 22537404
[TBL] [Abstract][Full Text] [Related]
28. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection.
Tong MJ; Weiner JM; Ashcavai MW; Redeker AG; Comparini S; Vyas GN
J Infect Dis; 1979 Oct; 140(4):506-12. PubMed ID: 229173
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5).
Berthillon P; Crance JM; Leveque F; Jouan A; Petit MA; Deloince R; Trepo C
J Hepatol; 1996 Jul; 25(1):15-9. PubMed ID: 8836896
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B surface antigen as a marker for recurrent, metastatic hepatocellular carcinoma after liver transplantation.
Hshieh TT; Sundaram V; Najarian RM; Hanto DW; Karp SJ; Curry MP
Liver Transpl; 2012 Aug; 18(8):995-8. PubMed ID: 22829419
[No Abstract] [Full Text] [Related]
32. Hepatitis B surface antigen and hepatocellular carcinoma in the People's Republic of China.
Ilardi CF; Ying YY; Ackerman LV; Elias JM
Cancer; 1980 Oct; 46(7):1612-6. PubMed ID: 6251965
[TBL] [Abstract][Full Text] [Related]
33. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
[TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
[TBL] [Abstract][Full Text] [Related]
36. Lack of leukocyte migration inhibition by hepatitis B surface antigen in hepatocellular carcinoma patients.
Lee CS; Chang KJ; Chen DS; Lin TY
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Sep; 12(3):86-92. PubMed ID: 94850
[TBL] [Abstract][Full Text] [Related]
37. Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
Yip TC; Chan HL; Wong VW; Tse YK; Lam KL; Wong GL
J Hepatol; 2017 Nov; 67(5):902-908. PubMed ID: 28652084
[TBL] [Abstract][Full Text] [Related]
38. Maternal transmission of hepatitis B surface antigen in patients with hepatocellular carcinoma in Taiwan.
Sung JL; Chen DS
Scand J Gastroenterol; 1980; 15(3):321-4. PubMed ID: 6254137
[TBL] [Abstract][Full Text] [Related]
39. In vivo detection of human hepatoma secreting hepatitis B surface antigen in nude mice with radiolabeled monoclonal antibodies that recognize distinct epitopes.
Henkel RD; Kennedy RC; Sparrow JT; Dreesman GR
Clin Immunol Immunopathol; 1985 May; 35(2):146-55. PubMed ID: 2416499
[TBL] [Abstract][Full Text] [Related]
40. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
